| Abstrakt: |
The objective of this quality improvement project was to decrease the amount of benzodiazepines (BZDs) prescribed by providers at a Midwestern university outpatient clinic. Clinic providers participated in a brief, live educational intervention combining academic detailing (i.e., the provision of current evidence about BZD) and pharmaceutical detailing (i.e., a sales technique borrowed from pharmaceutical companies). A 1% decrease in BZD prescribing was set as the measure of success. Using data from the electronic medical record, the monthly average of BZD prescriptions written within calendar year 2017 (before project launch) was compared to the number written 30 days after the intervention. Following the intervention, an 80% reduction in BZD prescribing was calculated. Combined academic and pharmaceutical detailing could be an effective way to change prescribing behavior in this provider population. Further investigation is needed to ascertain whether the change in prescribing behavior can be sustained, and that no harm is being done to patients who are currently dependent on BZD medications. [The objective of this quality improvement project was to decrease the amount of benzodiazepines (BZDs) prescribed by providers at a Midwestern university outpatient clinic. Clinic providers participated in a brief, live educational intervention combining academic detailing (i.e., the provision of current evidence about BZD) and pharmaceutical detailing (i.e., a sales technique borrowed from pharmaceutical companies). A 1% decrease in BZD prescribing was set as the measure of success. Using data from the electronic medical record, the monthly average of BZD prescriptions written within calendar year 2017 (before project launch) was compared to the number written 30 days after the intervention. Following the intervention, an 80% reduction in BZD prescribing was calculated. Combined academic and pharmaceutical detailing could be an effective way to change prescribing behavior in this provider population. Further investigation is needed to ascertain whether the change in prescribing behavior can be sustained, and that no harm is being done to patients who are currently dependent on BZD medications. [Journal of Psychosocial Nursing and Mental Health Services, 58(1), 39–45.] [ABSTRACT FROM AUTHOR] |
